316 related articles for article (PubMed ID: 15741002)
1. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
[TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
3. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
4. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
5. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
6. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
Hrdlicka M; Zedkova I; Blatny M; Urbanek T
Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
[TBL] [Abstract][Full Text] [Related]
7. Weight changes during clozapine treatment.
Briffa D; Meehan T
Aust N Z J Psychiatry; 1998 Oct; 32(5):718-21. PubMed ID: 9805596
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and weight gain.
Theisen FM; Cichon S; Linden A; Martin M; Remschmidt H; Hebebrand J
Am J Psychiatry; 2001 May; 158(5):816. PubMed ID: 11329412
[No Abstract] [Full Text] [Related]
9. Successful treatment with clozapine at higher doses after clozapine-induced priapism.
de Nesnera A
J Clin Psychiatry; 2003 Nov; 64(11):1394-5. PubMed ID: 14658959
[No Abstract] [Full Text] [Related]
10. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
[TBL] [Abstract][Full Text] [Related]
11. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
[TBL] [Abstract][Full Text] [Related]
12. Zonisamide-induced weight loss in schizophrenia: case series.
Yang J; Lee MS; Joe SH; Jung IK; Kim SH
Clin Neuropharmacol; 2010; 33(2):104-6. PubMed ID: 19935403
[TBL] [Abstract][Full Text] [Related]
13. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment.
Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ
Hum Psychopharmacol; 2010; 25(4):303-9. PubMed ID: 20521320
[TBL] [Abstract][Full Text] [Related]
14. Clozapine-associated weight loss.
Hanwella R; de Silva V; Wijeratne C; Ketharanathan T; de Silva J
J Psychopharmacol; 2010 Jul; 24(7):1127-9. PubMed ID: 19264815
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
[TBL] [Abstract][Full Text] [Related]
16. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
[TBL] [Abstract][Full Text] [Related]
17. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
18. Choice of an antipsychotic.
Med Lett Drugs Ther; 2003 Dec; 45(1172):102-4. PubMed ID: 14679353
[No Abstract] [Full Text] [Related]
19. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
[TBL] [Abstract][Full Text] [Related]
20. Importance of oral glucose tolerance test in patient with schizophrenia.
Margetić B; Aukst-Margetić B; Badanjak A
Psychiatr Danub; 2005 Jun; 17(1-2):94-6. PubMed ID: 16395850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
